Alpha 2.0
Login Register
» Articles » PMID: 34348841

Potential of Minocycline for Treatment of Resistant Hypertension

Overview
Journal Am J Cardiol
Specialty Cardiology & Vascular Diseases
Date 2021 Aug 5
PMID 34348841
Citations 5
Authors
Carl J Pepine
Alexander Thiel
Seungbum Kim
Eileen M Handberg
Elaine M Richards
Osama Dasa
Mohammed Mohammed
Steven M Smith
Rhonda M Cooper-DeHoff
Mohan K Raizada
Affiliations
Soon will be listed here.
Citing Articles

Microbiome-Based Therapeutics for Salt-Sensitive Hypertension: A Scoping Review.

Shremo Msdi A, Haghparast A, Garey K, Wang E Nutrients. 2025; 17(5).

PMID: 40077695 PMC: 11901721. DOI: 10.3390/nu17050825.

The KCa3.1 Channel Blocker TRAM-34 and Minocycline Prevent Fructose-Induced Hypertension in Rats.

Hamad A, Ozkan M Am J Hypertens. 2024; 37(12):995-1002.

PMID: 39189991 PMC: 11664185. DOI: 10.1093/ajh/hpae115.

Antioxidative and cardioprotective effects of minocycline in ischemia/reperfusion injury in experimental model of hypertension.

Rudic T, Stojanovic A, Sobot N, Novakovic J, Bolevich S, Bolevich S Mol Cell Biochem. 2024; 480(3):1747-1762.

PMID: 39187740 DOI: 10.1007/s11010-024-05095-w.

Reprograming of transcriptional profile of colonic organoids from patients with high blood pressure by minocycline.

Li J, Richards E, Pepine C, Handberg E, Smith S, Alakrad E Am Heart J Plus. 2024; 36.

PMID: 38222308 PMC: 10785309. DOI: 10.1016/j.ahjo.2023.100343.

Minocycline Reduces Hypothalamic Microglia Activation and Improves Metabolic Dysfunction in High Fat Diet-Induced Obese Mice.

Coker C, White M, Singal A, Bingaman S, Paul A, Arnold A Front Physiol. 2022; 13:933706.

PMID: 35784876 PMC: 9244633. DOI: 10.3389/fphys.2022.933706.